Paul N. Hopkins, MD, MSPH, FNLA

Research Interests

  • Hypertension
  • Lipids

Languages

  • English

Academic Information

  • Departments: Internal Medicine - Professor Emeritus
  • Divisions: Cardiovascular Genetics

Board Certification

  • American Board of Clinical Lipidology
  • American Board of Preventive Medicine (Public Health and General Preventive Medicine)

Academic Office Information

  • 801-585-5592
  • University Hospital
    Cardiovascular Genetics
    50 N Medical Dr, Room: 1160
    Salt Lake City, UT 84132

Academic Bio

Dr. Hopkins received his Bachelor of Science degree in Biochemistry from UCLA in 1997 (Magna cum laude) followed by a Master of Science in Public Health in 1978 also from UCLA. His medical training was at the University of Utah School of Medicine and the Mayo Graduate School of Medicine in Rochester Minnesota. He is board certified in Public Health and Preventive Medicine as well as Clinical Lipidology.
Dr. Hopkins has been involved in efforts to promote greater understanding and prevention of premature, familial coronary artery disease (CAD) with the Cardiovascular Genetics (CVG) group since 1978. He has been a Principal Investigator (PI) or Co-Investigator for numerous NIH grants focused on the genetics of CAD, hypertension, lipids, diabetes, and metabolic syndrome. Dr. Hopkins is currently Co-Director of Cardiovascular Genetics at the University of Utah and Director of the Cardiovascular Disease Prevention Clinic, a referral clinic for severe genetic lipid disorders, hypertriglyceridemia, familial combined hyperlipidemia, metabolic syndrome and diabetes, and familial hypercholesterolemia (FH). He has done extensive research among patients with FH and has been the PI for the Utah branch of several NIH studies including GOLDN (a study of pharmacogenetics of fenofibrate and effects on triglyceride metabolism), and the ongoing Genetics of Human Hypertension study (a collaboration with Harvard Medical School since 1986). He continues to have an intense interest in atherosclerosis disease prevention, familial lipid disorders, metabolic syndrome, and pathogenesis of diabetes and hypertension. He has served as a local PI for over 30 industry-funded clinical trials of various lipid interventions.
From 1998 to 2004 Dr. Hopkins was International Chair for the MEDPED program (Make Early Diagnoses to Prevent Early Death), started by the late Dr. Roger Williams to find, educate, and help prevent premature CAD in persons with FH. Dr. Hopkins served as an NIH grant reviewer and continues to be a reviewer for numerous medical journals. He teaches at the University of Utah School of Medicine, is an active lecturer, and serves as a statistical consultant for the Center for Clinical and Translational Studies statistics group at the University of Utah.

Research Statement

Dr. Hopkins has been involved in efforts to promote greater understanding and prevention of premature, familial coronary artery disease (CAD) with the Cardiovascular Genetics (CVG) group since 1978. He has been a Principal Investigator (PI) or Co-Investigator for numerous NIH grants focused on the genetics of CAD, hypertension, lipids, diabetes, and metabolic syndrome. He originated and directs the Cardiovascular Disease Prevention Clinic, a referral clinic for severe genetic lipid disorders such as familial hypercholesterolemia (FH), hypertriglyceridemia, metabolic syndrome, diabetes, and hypertension. Dr. Hopkins was PI of 2 NIH grants that focused on causes for differences in clinical CAD expression among patients with FH and has been the PI for the Utah branch of several NIH studies including GOLDN (a study of pharmacogenetics of fenofibrate and effects on triglyceride metabolism) and the ongoing Genetics of Human Hypertension study (an ongoing collaboration with Harvard Medical School since 1986). He has served as a local PI for over 30 industry-funded clinical trials of various lipid interventions. He continues to have an intense interest in familial lipid disorders, metabolic syndrome, and pathogenesis of atherosclerosis, diabetes, and hypertension.
From 1998 to 2004 Dr. Hopkins was International Chair for the MEDPED program (Make Early Diagnoses to Prevent Early Death), started by the late Dr. Roger Williams to find, educate, and help prevent premature CAD in persons with FH. He was recently invited to serve on the Scientific Advisory Board of the FH Foundation. Dr. Hopkins served on the Chronic Diseases Study Section, National Institutes of Health, from 2004 to 2008 and continues to be a reviewer for numerous medical journals. Dr. Hopkins has taught at the University of Utah School of Medicine, is an active lecturer, and serves as a statistics and epidemiology consultant for the Center for Clinical and Translational Studies statistics group at the University of Utah.

Education History

Type School Degree
Residency University of Utah School of Medicine
Preventive Medicine
Resident
Internship Mayo Graduate School of Medicine
Internal Medicine
Intern
Professional Medical University of Utah School of Medicine
Medicine
M.D.
Graduate Training University of California, Los Angeles
Nutrition & Public Health
M.S.P.H.
Undergraduate University of California, Los Angeles
Biochemistry
B.S.